Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Commun Biol ; 5(1): 370, 2022 04 19.
Article in English | MEDLINE | ID: mdl-35440795

ABSTRACT

The obesity epidemic continues to worsen worldwide. However, the mechanisms initiating glucose dysregulation in obesity remain poorly understood. We assessed the role that colonic macrophage subpopulations play in glucose homeostasis in mice fed a high-fat diet (HFD). Concurrent with glucose intolerance, pro-inflammatory/monocyte-derived colonic macrophages increased in mice fed a HFD. A link between macrophage numbers and glycemia was established by pharmacological dose-dependent ablation of macrophages. In particular, colon-specific macrophage depletion by intrarectal clodronate liposomes improved glucose tolerance, insulin sensitivity, and insulin secretion capacity. Colonic macrophage activation upon HFD was characterized by an interferon response and a change in mitochondrial metabolism, which converged in mTOR as a common regulator. Colon-specific mTOR inhibition reduced pro-inflammatory macrophages and ameliorated insulin secretion capacity, similar to colon-specific macrophage depletion, but did not affect insulin sensitivity. Thus, pharmacological targeting of colonic macrophages could become a potential therapy in obesity to improve glycemic control.


Subject(s)
Diet, High-Fat , Insulin Resistance , Animals , Blood Glucose/metabolism , Colon/metabolism , Diet, High-Fat/adverse effects , Glycemic Control , Macrophages/metabolism , Mice , Obesity/etiology , Obesity/metabolism , TOR Serine-Threonine Kinases/metabolism
2.
Sci Rep ; 10(1): 3035, 2020 02 20.
Article in English | MEDLINE | ID: mdl-32080229

ABSTRACT

Gestational diabetes mellitus (GDM) is one of the most common diseases associated with pregnancy, however, the underlying mechanisms remain unclear. Based on the well documented role of inflammation in type 2 diabetes, the aim was to investigate the role of inflammation in GDM. We established a mouse model for GDM on the basis of its two major risk factors, obesity and aging. In these GDM mice, we observed increased Interleukin-1ß (IL-1ß) expression in the uterus and the placenta along with elevated circulating IL-1ß concentrations compared to normoglycemic pregnant mice. Treatment with an anti-IL-1ß antibody improved glucose-tolerance of GDM mice without apparent deleterious effects for the fetus. Finally, IL-1ß antagonism showed a tendency for reduced plasma corticosterone concentrations, possibly explaining the metabolic improvement. We conclude that IL-1ß is a causal driver of impaired glucose tolerance in GDM.


Subject(s)
Diabetes, Gestational/metabolism , Hyperglycemia/complications , Hyperglycemia/metabolism , Interleukin-1beta/antagonists & inhibitors , Animals , Diabetes, Gestational/blood , Disease Models, Animal , Female , Hormones/blood , Hyperglycemia/blood , Interleukin-1beta/metabolism , Mice, Inbred C57BL , Pregnancy , Steroids/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...